Viewing Study NCT00536835


Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2026-02-27 @ 10:33 AM
Study NCT ID: NCT00536835
Status: COMPLETED
Last Update Posted: 2017-06-26
First Post: 2007-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess the Pharmacokinetics and Pharmacodynamics of GSK461364 in Subjects With Non-Hodgkins Lymphoma
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Non-Hodgkin View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Hodgkins Lymphoma View
None Cancer View
None First time in human View
None PLK1 inhibitor View
None Advanced Solid Tumor View
None GSK461364 View